Records containing: Metastatic Malignant Solid Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-30Molecular Analysis for Combination Therapy Choice (ComboMATCH)
-
CLINICAL_TRIALS study record update · 2026-10-30Pilot Phase I Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
-
CLINICAL_TRIALS study record update · 2026-10-29A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression
-
CLINICAL_TRIALS study record update · 2026-10-28Phase I Trial of ZEN003694 (ZEN-3694) in Combination With Capecitabine in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-27Phase 1 Study of Trastuzumab Deruxtecan (DS-8201a) in Combination With Azenosertib (ZN-c3) in HER2-Expressing/Amplified Gastric/Gastroesophageal Junction Cancer and Other Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-10-16Phase 1b Study of Pidnarulex and Trastuzumab Deruxtecan in Patients With HER2 Expressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-10-13Knight Cancer Institute Study of Histology-Agnostic Immunotherapy With Focus on Timing: - Knight SHIFT - A Prospective, Multi-Histology Pragmatic Study
-
CLINICAL_TRIALS study record update · 2026-10-02Phase I Trial of DS-8201a (Trastuzumab Deruxtecan) in Combination With Neratinib in Solid Tumors With HER2 Alterations
-
CLINICAL_TRIALS study record update · 2026-09-25Phase I Clinical Trial of M6620 (VX-970, Berzosertib) in Combination With the Topoisomerase I Inhibitor Irinotecan in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-08-25A Phase Ib/II Basket Study of BMS-986504 in Combination With Pemetrexed for Metastatic Solid Tumors With MTAP Deletion
-
CLINICAL_TRIALS study record update · 2026-08-20Phase IB Trial of Niraparib and Dostarlimab (TSR-042) in Patients With BRCA-Mutated Breast, Pancreas or Ovary Cancer
-
CLINICAL_TRIALS study record update · 2026-05-19BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA)
-
CLINICAL_TRIALS study record update · 2026-04-27Molecular Analysis for Combination Therapy Choice (ComboMATCH)
-
CLINICAL_TRIALS study record update · 2026-04-24Phase I Trial of ZEN003694 (ZEN-3694) in Combination With Capecitabine in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-24DS3201 With Ipilimumab in Patients With Metastatic Aggressive Variant Prostate (AVPC), Urothelial (UC), and Renal Cell (RCC) Carcinomas
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-24Molecular Analysis for Combination Therapy Choice (ComboMATCH)
-
CLINICAL_TRIALS study record update · 2026-04-24A Randomized Phase II Study of AMG 510 (Sotorasib) With or Without Panitumumab in Advanced Solid Tumors: A ComboMATCH Treatment Trial
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase I Trial of Vemurafenib in Combination With Cetuximab and Irinotecan in Patients With BRAF V600 Mutant Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-23NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
-
CLINICAL_TRIALS study record update · 2026-04-23Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)
-
CLINICAL_TRIALS study record update · 2026-04-23Phase II Trial of Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Selected Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-21A Pilot Study of Atezolizumab (MPDL3280A) Following Adoptive Cell Transfer in Active Hematologic or Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase II Basket Study of the Oral TRK Inhibitor Larotrectinib (BAY2757556) in Subjects With NTRK Amplification Positive and Pan-TRK Positive Tumors